Photo courtesy of Cummings Properties

A medical device start-up has inked a lease that will see it trade in lab space in a UMass Lowell incubator for new offices in Woburn.

Qlibrium will take 4,700 square feet in the Cummings Properties-managed 16 Tower Office Park after previously occupying space in the Massachusetts Medical Device Development Center.

Formerly known as Cam Med Inc., Qlibrium was founded in 2014 with the aim of developing an improved platform for injectable drug delivery. Its QLib OBDS (On-Body Delivery System) platform is a wearable ultra-thin and lightweight pump equipped to deliver liquid medications via injection.

Qlibrium was selected as a MassChallenge Gold Winner in 2014 and one of MedTech Innovator’s Top 100 Companies in 2017.

“The space is well-suited for us as we enter our next stage of growth and is situated within 20 minutes’ drive of many of our current and potential strategic partners,” Qlibrium CEO Larry Alberts said in a statement.

Cummings Properties was represented by its Senior Leasing Director Rob Yacobian, while T3 Advisors partner Austin Barrett represented Qlibrium.

“Having come from an incubator environment, Qlibrium was focused on locating its new facility in a medtech hub with ready access to a strong science-oriented talent pool and area amenities,” Yacobian said in a statement. “We were pleased to accommodate the firm’s expansion in Woburn’s thriving biotech cluster.”

Among Qlibrium’s new neighbors are biotech firms Amgen, Azurity Pharmaceuticals, Covaris, HD Lifesciences, Medtronic, Minovia Therapeutics, and Verdox.